Fundraising Fox

Chris Jewell

Executive at Cartesian Therapeutics (NASDAQ: RNAC)

Washington DC-Baltimore Area

Find your path to Chris

714 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.

Crystal HuangunlockedChris: together at Harvard University (2010–2011)
×2Chris: together at Massachusetts Institute of Technology
×3Chris: together at Harvard University
Chris: together at University of Maryland

Executive at Cartesian Therapeutics (NASDAQ: RNAC)

Intro paths

→

In turn, Chris can intro founders to Cartesian Therapeutics (NASDAQ: RNAC)'s investors below.

Cartesian Therapeutics (NASDAQ: RNAC)'s investors · 8

+ND CapitalWoodside · $540K – $5.4M checksK2 HealthVenturesBoston · $10M – $100M checksMaryland TEDCOUpper Marlboro · $500K – $1.5M checksNational Institutes of Health (NIH)since 2018Polaris PartnersBoston · $500K – $5M checks · since 2016RUSNANOMoscowSchooner CapitalBostonTEDCOColumbia

Co-founders at Cartesian Therapeutics (NASDAQ: RNAC)

MK
Metin KurtogluExecutive Officer
OF
Omid FarokhzadDirector

Experience

  1. Blackbird LaboratoriesEntrepreneur in Residencecurrent2026 — present
  2. CREATE MedicinesAdvisory Board Member (SAB)current2026 — present
  3. Aletira TherapeuticsBoard Member (observer) and Senior Advisorcurrent2026 — present
  4. Allometra MaterialsCo-Founder and Board membercurrent2026 — present
  5. Nodal TherapeuticsFoundercurrent2024 — presentMaryland, United States
  6. University of MarylandInstitute Professor of Translational Engineering (Endowed)2012 — 2026
  7. Cartesian TherapeuticsChief Scientific Officer and Senior Vice President2023 — 2026Gaithersburg, MD
  8. United States Department of Veterans AffairsResearch Biologist2017 — 2026
  9. Start-ups and Global firmsConsulting, Biotechnology and Pharmaceutical industries2008 — 2026
  10. VaccitechScientific Advisory Board, Chairperson2021 — 2022
  11. Avidea TechnologiesScientific Advisory Board, Chairperson2019 — 2021
  12. Massachusetts Institute of TechnologyRagon Postdoctoral Fellow2009 — 2012
  13. Harvard UniversityVisiting Scientist2010 — 2012
  14. The Boston Consulting GroupConsultant2008 — 2009
  15. University of Wisconsin-MadisonGraduate Student (Lynn Research Group)2003 — 2008
  16. Akzo NobelInternational Intern2003
  17. MerckEngineering and Technology Fellow (Summers)2001 — 2002
  18. Procter & GambleIntern associate2000

Skills & more

Early Stage InvestmentBoard LevelEntrepreneurial OrganizationsBoard GovernanceBoard level experienceC SuiteAutoimmunityCancer ImmunotherapyCell TherapyLeadershipImmunologyStrategy
+12 moreNanotechnologyBiotechnologyManagement ConsultingVaccinesR&DBioengineeringChemical EngineeringMolecular BiologyDrug DeliveryPolymersBiomaterialsPharmaceutical Industry

From Chris's professional profile.

Frequently asked questions

Who is Chris Jewell?
Executive Officer at Cartesian Therapeutics (NASDAQ: RNAC)
Where does Chris Jewell work?
Chris Jewell is Executive at Cartesian Therapeutics (NASDAQ: RNAC).
Where did Chris Jewell go to school?
Chris Jewell studied at Massachusetts Institute of Technology (Postdoctoral Fellow, Immunology/Bioengineering); Harvard University (Ragon Postdoctoral Fellow/Visiting Scientist, Immunology); University of Wisconsin-Madison (M.S., Chemical Engineering).

Same school

Also attended Massachusetts Institute of Technology2,000

Fred WilsonCo-founder & Partner at Union Square VenturesElad GilSolo general partner investing through Gil CapitalAileen LeeFounder & Managing Partner of Cowboy VenturesHemant TanejaCEO & Managing Director of General CatalystPhilippe LaffontFounder & CIO of Coatue ManagementNat FriedmanCo-lead of Meta Superintelligence Labs; co-founder of NFDG

+ 1,994 more

Also attended Harvard University2,000

Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG

+ 1,994 more

Also attended University of Wisconsin-Madison504

Zhenyu TangInvestment Director at Intel CapitalDougAdvisor at Clear VenturesDan RuchPartner at Rho VenturesJoe HayesInvestor at LightbankGeorge RobertsInvestor at OpenView Venture PartnersBret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer Capital

+ 498 more

Also attended Lehigh University162

Joseph R. SavianoFounder and Managing Member at Dot CapitalStuart SchnabolkChief Financial Officer at Ibex InvestorsEric HeilManaging Partner at Medical Excellence CapitalHa DaoAssociate at PROOFJay FraserInvestor at Side Door VenturesMegan CainPrincipal at The Westly Group

+ 156 more

Shared employers

Also worked at Aletira Therapeutics1

Ram AiyarChief Executive Officer, President and Director at Korro Bio

Also worked at Cartesian Therapeutics3

Carsten BrunnPresident, CEO & Chairman of the Board at Cartesian Therapeutics (NASDAQ: RNAC)Blaine DavisExecutive Officer at Cartesian Therapeutics (NASDAQ: RNAC)Peter G TraberExecutive Officer, Director at Galectin Therapeutics

Also worked at Vaccitech4

Andrew McLeanManaging Partner at Tin Alley VenturesDr Andrew McLeanManaging partner at Tin Alley VenturesAlex HammacherHead of Strategic Operations & Corporate Finance at Oxford Science EnterprisesRichard OakleyPrincipal, Deep Tech at Oxford Science Enterprises

Also worked at Procter & Gamble398

Ken ChenaultInvestment Team at General CatalystDavid JohnsonManaging Director at Intel Capital, North AmericaKenneth Morand, Ph.D.Life Sciences Partner at CincyTechChad SummeBoard Member at CincyTechDjoni de VosPrincipal at Keen Venture PartnersAllison KuziwGlobal Human Resources Executive at Marlin Equity Partners

+ 392 more